Search
Search Results
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, October 2022
- Subject(s):
- Biological Products
Drug Approval
Government Regulation
United States
United States. Food and Drug Administration
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2011
- Subject(s):
- Drug Costs -- trends
Drug Therapy -- statistics & numerical data
Economic Competition
Pharmaceutical Preparations -- economics
Drug Approval
Drug Costs -- statistics & numerical data
Forecasting
Medicare Part D -- economics
Patents as Topic
Humans
United States
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, June 2020
- Subject(s):
- Drug Approval
Drug Industry
Drug Labeling
Risk Evaluation and Mitigation
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- [Silver Spring, MD] : Center for Drug Evaluation and Research, May 2020
- Subject(s):
- Biological Products
COVID-19 -- drug therapy
Drug Approval
Drug Industry
Drugs, Investigational
Drug Evaluation, Preclinical
Investigational New Drug Application
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, September 2020
- Subject(s):
- Drug Approval
Drug Industry
Drugs, Generic
Therapeutic Equivalency
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, October 2020
- Subject(s):
- Drug Approval
Drugs, Generic
Reference Books, Medical
Therapeutic Equivalency
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, November 2020
- Subject(s):
- Drug Approval
Drug Development -- methods
Drug Development -- standards
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, November 2020
- Subject(s):
- Drug Approval
Drug Development
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, November 2020
- Subject(s):
- Drug Approval
Prescription Drugs
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
- Publication:
- [Silver Spring, MD] : Center for Drug Evaluation and Research, January 2021
- Subject(s):
- Drug Approval
Patient Safety
Therapeutic Equivalency
COVID-19
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration
